B
MEDP icon

Bayban’s Medpace MEDP Stock Holding History

Bayban’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Sell
78
-14
-15% -$6.46K 0.03% 254
2026
Q1 		$44.2K Buy
92
+14
+18% +$7.17K 0.04% 238
2025
Q4 		$43.8K Buy
+78
New +$44.3K 0.04% 244

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bayban's MEDP Position: Q2 2026 in Review

Bayban reduced its Medpace (MEDP) stake by 15% in Q2 2026, selling an estimated $6.46K and leaving 78 shares worth $41.3K. The position accounts for 0.03% of the portfolio, ranked #254.

Bayban first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $44.2K in Q1 2026. 661 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bayban held 78 shares of Medpace worth $41.3K as of Q2 2026.
  • Bayban sold 14 Medpace shares in Q2 2026, an estimated $6.46K.
  • Medpace made up 0.03% of Bayban's portfolio in Q2 2026, its #254 holding.
  • Bayban first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Bayban's Medpace position peaked at $44.2K in Q1 2026.
  • 661 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.